LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 29 Jan 2026
Drug Safety Update

GLP

Published on 29 Jan 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has been further updated to highli…
Drug Safety Update on GOV.UK ↗ All events: GLP

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has been further updated to highlight the potential risk of severe acute pancreatitis with these products, including rare reports of necrotising and fatal pancreatitis.

Other events for GLP

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.